Experts at UCL and spinout company Odin Vision working with clinicians at UCLH have used artificial intelligence (AI) to help detect early signs of oesophageal cancer.

Rockley Photonics has unveiled today its game-changing health monitoring wearable to be used in trial studies.

A final-year design student at Loughborough University, UK, has invented a device that seals open knife wounds in 30 seconds.

After locking down 510(k) clearance from the FDA in March 2020, EchoNous is now on track to begin the commercial rollout of the Kosmos platform, backed by a recent influx of funding.

A team of researchers uncovers how the COVID-19 vaccines that use adenovirus vectors trigger the rare, blood clotting reaction known as VITT.

Researchers at Kumamoto University in Japan have designed an inexpensive and convenient filter that can isolate circulating tumor cells from as little as 1 mL of patient blood. The highly sensitive filter can successfully work in samples containing as few as five tumor cells in 1 mL of blood, and does not require expensive equipment or reagents, unlike certain pre-existing cell capture technologies.

A new study by researchers at the University of Eastern Finland shows for the first time that blood-based measurement of glial fibrillary acidic protein (GFAP) enables distinguishing patients with frontotemporal dementia from those with primary psychiatric disorders or healthy individuals.

In a new study, scientists discuss the development of a rapid COVID-19 diagnostic tool known as the Low-cost Electrochemical Advanced Diagnostic (LEAD).

Automating validation processes gives manufacturers the flexibility and capability to make changes, updates and re-validation, making it easier to upgrade or add new MES modules to their process. Simplifying the process through automation leads to faster ROI and time to market.

Most of the tests that doctors use to diagnose cancer—such as mammography, colonoscopy, and CT scans—are based on imaging. More recently, researchers have also developed molecular diagnostics that can detect specific cancer-associated molecules that circulate in bodily fluids like blood or urine.